CAS: 1402709-93-6
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | CCT241736 REF: IN-DA01ENWXCAS: 1402709-93-6 | 99% | A consultar | Mié 08 Ene 25 |
 | CCT241736 REF: TM-T4428CAS: 1402709-93-6 | 96.2% - 99.88% | 59,00 €~482,00 € | Mié 15 Ene 25 |
 | CCT241736 REF: 3D-CGC70993CAS: 1402709-93-6 | Min. 95% | A consultar | Mié 19 Feb 25 |
Ref: IN-DA01ENWX
| 1mg | 67,00 € | ||
| 5mg | 129,00 € | ||
| 10mg | 148,00 € | ||
| 25mg | 313,00 € | ||
| 50mg | 498,00 € | ||
| 100mg | A consultar | ||
| 200mg | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 8 de Enero de 2025
CCT241736
CAS:1402709-93-6
CCT241736 is an orally bioavailable dual FLT3/Aurora kinase inhibitor that also inhibits clinically relevant FLT3-resistant …
Fórmula:
C22H23Cl2N7
Pureza:
96.2% - 99.88%
Forma y color:
Solid
Peso molecular:
456.37
Ref: TM-T4428
| 5mg | 59,00 € | ||
| 10mg | 96,00 € | ||
| 25mg | 167,00 € | ||
| 50mg | 323,00 € | ||
| 100mg | 482,00 € | ||
| 1mL*10mM (DMSO) | 67,00 € |
Entrega estimada en Estados Unidos, el Miércoles 15 de Enero de 2025
CCT241736
CAS:1402709-93-6
CCT241736 is an effective dose of a clinical drug that belongs to the class of …
Fórmula:
C22H23Cl2N7
Pureza:
Min. 95%
Peso molecular:
456.37 g/mol
Ref: 3D-CGC70993
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 19 de Febrero de 2025
